SCHEMBL28114823

SCHEMBL28114823

Oc1ccc(C2=Cc3ccccc3C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.53
CYP11B2 P19099 2/20 0.53
PTGS2 P35354 2/20 0.45
IP6K1 Q92551 1/20 0.43
IP6K3 Q96PC2 1/20 0.43
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
ESR2 Q92731 4/20 0.41
ESR1 P03372 3/20 0.41
CYP19A1 P11511 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
NISCH Q9Y2I1 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11209313 0.85 CYP11B1 (0.56) CYP11B1CYP11B2PTGS2MMP3BCL2L1
SCHEMBL8058170 0.84 CYP11B2 (0.61) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL6285180 0.84 CYP11B2 (0.61) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL319265 0.84 CYP11B2 (0.65) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL31608568 0.84 CYP11B2 (0.65) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL6287169 0.82 CYP11B1 (0.54) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL30487694 0.82 CYP11B1 (0.54) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL31666281 0.82 CYP11B2 (0.62) CYP11B1CYP11B2PTGS2IP6K1IP6K3
SCHEMBL22568909 0.81 CYP11B1 (0.45) CYP11B1CYP11B2PTGS2MMP3BCL2L1
SCHEMBL19432718 0.81 MMP3 (0.48) CYP11B1CYP11B2MMP3BCL2L1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105849096-B Piperidine derivatives having multimodal activity against pain 埃斯蒂文制药股份有限公司 2019-11-29 CN disclosed
CN-104066730-B Heterocyclic compounds and their use as type III receptor tyrosine kinase modulators 埃姆比特生物科学公司 2017-03-08 CN disclosed